| Stage | PENG | % of rev | NVDA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $567M | 100.00% | $96.2B | 100.00% | NVDA ×169.80 |
| Gross profit | $156M | 27.51% | $72.1B | 74.98% | NVDA +47.5pp |
| Operating income | $69M | 12.26% | $63.7B | 66.24% | NVDA +54.0pp |
| Pre-tax income | $37M | 6.60% | $71.5B | 74.32% | NVDA +67.7pp |
| Net income | $95M | 16.77% | $59.7B | 62.03% | NVDA +45.3pp |
| Stage | PENG | NVDA | Gap · A − B |
|---|---|---|---|
| Revenue | $567M100.00% | $96.2B100.00% | NVDA ×169.80 |
| Gross profit | 27.51%$156M | 74.98%$72.1B | NVDA +47.5pp |
| Operating income | 12.26%$69M | 66.24%$63.7B | NVDA +54.0pp |
| Pre-tax income | 6.60%$37M | 74.32%$71.5B | NVDA +67.7pp |
| Net income |
| 16.77%$95M |
| 62.03%$59.7B |
| NVDA +45.3pp |
No shared counterparties.